Minerva Neurosciences, Inc.NERVNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank21
3Y CAGR-26.7%
5Y CAGR-23.5%
Year-over-Year Change
Research and development spending
3Y CAGR
-26.7%/yr
vs -19.5%/yr prior
5Y CAGR
-23.5%/yr
Recent deceleration
Acceleration
-7.2pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $5.76M | -51.6% |
| 2024 | $11.90M | -6.3% |
| 2023 | $12.71M | -13.3% |
| 2022 | $14.65M | -54.3% |
| 2021 | $32.04M | +45.4% |
| 2020 | $22.04M | -62.1% |
| 2019 | $58.12M | +66.6% |
| 2018 | $34.89M | +15.3% |
| 2017 | $30.26M | +48.0% |
| 2016 | $20.44M | - |